PC
GILD icon

Passport Capital’s Gilead Sciences GILD Stock Holding History

Passport Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,224
Closed -$255K – 118
2016
Q3 		$255K Sell
3,224
-727,248
-100% -$59.1M 0.01% 121
2016
Q2 		$60.9M Buy
+730,472
New +$64.8M 1.11% 28
2015
Q4 		– Sell
-29,586
Closed -$2.9M – 132
2015
Q3 		$2.9M Buy
29,586
+27,291
+1,189% +$3.03M 0.05% 88
2015
Q2 		$269K Sell
2,295
-43,357
-95% -$4.74M 0.01% 159
2015
Q1 		$4.48M Buy
45,652
+7,902
+21% +$802K 0.12% 85
2014
Q4 		$3.56M Buy
37,750
+25,677
+213% +$2.66M 0.09% 92
2014
Q3 		$1.28M Buy
12,073
+8,299
+220% +$813K 0.02% 112
2014
Q2 		$313K Buy
3,774
+155
+4% +$12.1K 0.01% 128
2014
Q1 		$256K Buy
+3,619
New +$284K 0.01% 136

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Passport Capital's GILD Position: Q4 2016 in Review

Passport Capital sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 3,224 shares — an estimated $255K sold.

Passport Capital first reported a position in GILD in Q1 2014 and held it in 9 quarters. The position peaked at $60.9M in Q2 2016. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Passport Capital reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Passport Capital sold 3,224 Gilead Sciences shares in Q4 2016, an estimated $255K.
  • Passport Capital first reported a position in Gilead Sciences in Q1 2014 and held it in 9 quarters.
  • Passport Capital's Gilead Sciences position peaked at $60.9M in Q2 2016.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Passport Capital's 13F filing for Q4 2016, filed 14 Feb 2017.